Literature DB >> 7713585

The role of the lymphocyte in an immune response.

K Balakrishnan1, L E Adams.   

Abstract

The immune system has evolved in the human being as an elaborate mechanism to distinguish itself from all else that is not self. This process serves in the defence against invaders. The cells of the immune system learn to tolerate all tissues, cells and proteins of the body. Failure to control the state of tolerance results in autoimmunity. The understanding of the role of T-cell receptors (TCR), the Major Histocompatibility Complex (MHC), adhesion molecules and growth factors in antigen recognition has lead to the exploration of various means to modulate the immune response. Safety measures exist to prevent the immune system from attacking its host. The antigen has to be recognized by the T-cell. This involves the TCR and the MHC. In addition it must receive a second signal to become activated. The second signal involves a protein such as B7 binding with CD28. Certain specialized cells, macrophages, dendritic cells and activated B-cells can deliver this second signal for activation; receipt of only one signal can prevent activation. The elucidation of the role of cell-to-cell interactions, the adhesion molecules involved and the accessory growth factors provides modalities for selectively modifying the immune response. This would be of great relevance in autoimmunity and transplantation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7713585     DOI: 10.3109/08820139509062775

Source DB:  PubMed          Journal:  Immunol Invest        ISSN: 0882-0139            Impact factor:   3.657


  9 in total

1.  Characterisation of four major histocompatibility complex class II genes of the koala (Phascolarctos cinereus).

Authors:  Quintin Lau; Sarah E Jobbins; Katherine Belov; Damien P Higgins
Journal:  Immunogenetics       Date:  2012-10-23       Impact factor: 2.846

2.  MHC class II diversity of koala (Phascolarctos cinereus) populations across their range.

Authors:  Q Lau; W Jaratlerdsiri; J E Griffith; J Gongora; D P Higgins
Journal:  Heredity (Edinb)       Date:  2014-04-02       Impact factor: 3.821

3.  Identification of MHCII variants associated with chlamydial disease in the koala (Phascolarctos cinereus).

Authors:  Quintin Lau; Joanna E Griffith; Damien P Higgins
Journal:  PeerJ       Date:  2014-06-19       Impact factor: 2.984

4.  Disentangling the mechanisms of mate choice in a captive koala population.

Authors:  Parice A Brandies; Catherine E Grueber; Jamie A Ivy; Carolyn J Hogg; Katherine Belov
Journal:  PeerJ       Date:  2018-08-21       Impact factor: 2.984

5.  The prognostic value of platelet-to-lymphocyte ratio on in-hospital mortality in admitted adult traffic accident patients.

Authors:  Sion Jo; Taeoh Jeong; Jae Baek Lee; Youngho Jin; Jaechol Yoon; Boyoung Park
Journal:  PLoS One       Date:  2020-06-17       Impact factor: 3.240

6.  Platelet-Lymphocyte and Neutrophil-Lymphocyte Ratio for Prediction of Hospital Outcomes in Patients with Abdominal Trauma.

Authors:  Ayman El-Menyar; Ahammed Mekkodathil; Amani Al-Ansari; Mohammad Asim; Eman Elmenyar; Sandro Rizoli; Hassan Al-Thani
Journal:  Biomed Res Int       Date:  2022-02-07       Impact factor: 3.411

Review 7.  Immunomodulatory properties of cacao extracts - potential consequences for medical applications.

Authors:  Kathrin Becker; Simon Geisler; Florian Ueberall; Dietmar Fuchs; Johanna M Gostner
Journal:  Front Pharmacol       Date:  2013-12-12       Impact factor: 5.810

8.  Differential Response of B Cells to an Immunogen, a Mitogen and a Chemical Carcinogen in a Mouse Model System

Authors:  Nimisha Saxena; Amar Preet Kaur; Nimai Chand Chandra
Journal:  Asian Pac J Cancer Prev       Date:  2018-01-27

9.  Co-infections of human herpesviruses (CMV, HHV-6, HHV-7 and EBV) in non-transplant acute leukemia patients undergoing chemotherapy.

Authors:  Imene Handous; Bechir Achour; Manel Marzouk; Sana Rouis; Olfa Hazgui; Ines Brini; Abderrahim Khelif; Naila Hannachi; Jalel Boukadida
Journal:  Virol J       Date:  2020-03-17       Impact factor: 4.099

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.